205 related articles for article (PubMed ID: 32937681)
1. Patient and caregiver preferences for haemophilia A treatments: A discrete choice experiment.
Su J; Li N; Joshi N; Ng X; Botteman M; Shah R; Jain N; Lyn N; Preblick R
Haemophilia; 2020 Nov; 26(6):e291-e299. PubMed ID: 32937681
[TBL] [Abstract][Full Text] [Related]
2. Patient and caregiver preferences for haemophilia treatments: A discrete-choice experiment.
Garcia VC; Mansfield C; Pierce A; Leach C; Smith JC; Afonso M
Haemophilia; 2024 Mar; 30(2):375-387. PubMed ID: 38198352
[TBL] [Abstract][Full Text] [Related]
3. Treatment preferences in people with haemophilia A or caregivers of people with haemophilia A: A discrete choice experiment.
Fifer S; Kerr AM; Parken C; Hamrosi K; Eid S
Haemophilia; 2020 Aug; 26 Suppl 5():30-40. PubMed ID: 32935396
[TBL] [Abstract][Full Text] [Related]
4. Patient preferences and priorities for haemophilia gene therapy in the US: A discrete choice experiment.
Witkop M; Morgan G; O'Hara J; Recht M; Buckner TW; Nugent D; Curtis R; O'Mahony B; Skinner MW; Mulhern B; Cawson M; Ali TM; Sawyer EK; Li N
Haemophilia; 2021 Sep; 27(5):769-782. PubMed ID: 34310811
[TBL] [Abstract][Full Text] [Related]
5. The perspective of patients with haemophilia with inhibitors and their care givers: preferences for treatment characteristics.
Brown TM; Pashos CL; Joshi AV; Lee WC
Haemophilia; 2011 May; 17(3):476-82. PubMed ID: 21091851
[TBL] [Abstract][Full Text] [Related]
6. Preference-based valuation of treatment attributes in haemophilia A using web survey.
Steen Carlsson K; Andersson E; Berntorp E
Haemophilia; 2017 Nov; 23(6):894-903. PubMed ID: 28851125
[TBL] [Abstract][Full Text] [Related]
7. Patient and caregiver benefit-risk preferences for nonmetastatic castration-resistant prostate cancer treatment.
Srinivas S; Mohamed AF; Appukkuttan S; Botteman M; Ng X; Joshi N; Tsai JH; Fang J; Waldeck AR; Simmons SJ
Cancer Med; 2020 Sep; 9(18):6586-6596. PubMed ID: 32725755
[TBL] [Abstract][Full Text] [Related]
8. Patient and parent preferences for haemophilia A treatments.
Mohamed AF; Epstein JD; Li-McLeod JM
Haemophilia; 2011 Mar; 17(2):209-14. PubMed ID: 21070493
[TBL] [Abstract][Full Text] [Related]
9. Comparing Discrete Choice Experiment with Swing Weighting to Estimate Attribute Relative Importance: A Case Study in Lung Cancer Patient Preferences.
Veldwijk J; Smith IP; Oliveri S; Petrocchi S; Smith MY; Lanzoni L; Janssens R; Huys I; de Wit GA; Groothuis-Oudshoorn CGM
Med Decis Making; 2024 Feb; 44(2):203-216. PubMed ID: 38178591
[TBL] [Abstract][Full Text] [Related]
10. Care Management for Youth With Comorbid Developmental and Mental Health Conditions: A Discrete Choice Experiment Pilot Study.
dosReis S; N'Dri L; Ross M; Camelo Castillo W; Reeves G; Butler B
Acad Pediatr; 2020 Mar; 20(2):241-249. PubMed ID: 31128382
[TBL] [Abstract][Full Text] [Related]
11. Patients' and parents' satisfaction with, and preference for, haemophilia A treatments: a cross-sectional, multicentre, observational study.
Park YS; Hwang TJ; Cho GJ; Kim SK; Park SK; Kim JY; Baek HJ; Kim YJ; Lee HJ; Shin JS; Nam CM; Sun J; Yoo KY
Haemophilia; 2021 Jul; 27(4):563-573. PubMed ID: 34128300
[TBL] [Abstract][Full Text] [Related]
12. Assessing patients' and caregivers' perspectives on stability of factor VIII products for haemophilia A: a web-based study in the United States and Canada.
DiBenedetti DB; Coles TM; Sharma T; Pericleous L; Kulkarni R
Haemophilia; 2014 Jul; 20(4):e296-303. PubMed ID: 24870350
[TBL] [Abstract][Full Text] [Related]
13. Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular Degeneration.
Danner M; Vennedey V; Hiligsmann M; Fauser S; Gross C; Stock S
Value Health; 2017 Sep; 20(8):1166-1173. PubMed ID: 28964450
[TBL] [Abstract][Full Text] [Related]
14. Facilitating the implementation of pharmacokinetic-guided dosing of prophylaxis in haemophilia care by discrete choice experiment.
Lock J; de Bekker-Grob EW; Urhan G; Peters M; Meijer K; Brons P; van der Meer FJ; Driessens MH; Collins PW; Fijnvandraat K; Leebeek FW; Cnossen MH;
Haemophilia; 2016 Jan; 22(1):e1-e10. PubMed ID: 26612493
[TBL] [Abstract][Full Text] [Related]
15. Examining patient and professional perspectives in the UK for gene therapy in haemophilia.
Woollacott I; Morgan G; Chowdary P; O'Hara J; Franks B; van Overbeeke E; Dunn N; Michelsen S; Huys I; Martin A; Cawson M; Brownrigg J; Winburn I; Thomson J
Haemophilia; 2022 Jul; 28(4):588-609. PubMed ID: 35438818
[TBL] [Abstract][Full Text] [Related]
16. Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors.
Qian Y; Arellano J; Hauber AB; Mohamed AF; Gonzalez JM; Hechmati G; Gatta F; Harrelson S; Campbell-Baird C
Patient; 2016 Aug; 9(4):323-33. PubMed ID: 26821359
[TBL] [Abstract][Full Text] [Related]
17. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
[TBL] [Abstract][Full Text] [Related]
18. Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective.
Johnston KM; Audhya IF; Dunne J; Feeny D; Neumann P; Malone DC; Szabo SM; Gooch KL
Appl Health Econ Health Policy; 2024 May; 22(3):343-352. PubMed ID: 38253973
[TBL] [Abstract][Full Text] [Related]
19. Patient versus neurologist preferences: A discrete choice experiment for antiepileptic drug therapies.
Ettinger AB; Carter JA; Rajagopalan K
Epilepsy Behav; 2018 Mar; 80():247-253. PubMed ID: 29433949
[TBL] [Abstract][Full Text] [Related]
20. Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experiment.
Monnette A; Chen E; Hong D; Bazzano A; Dixon S; Arnold WD; Shi L
Orphanet J Rare Dis; 2021 Jan; 16(1):36. PubMed ID: 33472673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
